Solanezumab
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | amyloid-β |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
Chemical and physical data | |
Formula | C6396H9922N1712O1996S42 |
Molar mass | 144084.24 g·mol−1 |
Solanezumab (proposed INN) is a monoclonal antibody used as a neuroprotector.[1]
References
- ^ International Nonproprietary Names for Pharmaceutical Substances (INN, prepublication copy), World Health Organization.